EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Johnson & Johnson's enterprise value is $385,137 Mil.
Johnson & Johnson's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $89,331 Mil. Therefore, Johnson & Johnson's EV-to-Revenue for today is 4.31.
The historical rank and industry rank for Johnson & Johnson's EV-to-Revenue or its related term are showing as below:
XKAZ:JNJ_KZ'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.36 Med: 4.76 Max: 6.14
Current: 4.32
During the past 13 years, the highest EV-to-Revenue of Johnson & Johnson was 6.14. The lowest was 3.36. And the median was 4.76.
XKAZ:JNJ_KZ's EV-to-Revenue is ranked worse than 72.72% of 975
companies
in the Drug Manufacturers industry
Industry Median: 2.29
vs XKAZ:JNJ_KZ: 4.32
The historical data trend for Johnson & Johnson's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Johnson & Johnson's EV-to-Revenue
For the Drug Manufacturers - General subindustry, Johnson & Johnson's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson & Johnson's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Johnson & Johnson's EV-to-Revenue falls into.
Johnson & Johnson's current Enterprise Value is $385,137 Mil.
Johnson & Johnson's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $89,331 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson & Johnson (XKAZ:JNJ_KZ) EV-to-Revenue Explanation
Johnson & Johnson's share price for today is $156.14.
Johnson & Johnson's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $36.83.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson & Johnson EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Johnson & Johnson's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKAZ:JNJ_KZ has been successfully added to your 